| Capital Access Window - Ondine Biomedical Inc. | 30-Sep-2026 | 07:30 | RNS |
| Capital Access Window | 30-Sep-2026 | 07:00 | RNS |
| 2026 Interim Results & Post-Period Momentum | 30-Sep-2026 | 07:00 | RNS |
| Ondine and Mela Advance NHS ICU Market Access | 29-Sep-2026 | 07:00 | RNS |
| Steriwave Deploys in 5 Southern Ontario Hospitals | 23-Sep-2026 | 07:00 | RNS |
| Investor Presentation of Phase 3 Topline Results | 10-Sep-2026 | 07:00 | RNS |
| Largest Private Mexican Network Pilots Steriwave | 07-Sep-2026 | 07:00 | RNS |
| Notification of major holdings | 04-Sep-2026 | 07:00 | RNS |
| Notification of major holdings - Pentwater | 03-Sep-2026 | 09:59 | RNS |
| Positive Topline Results in US Phase 3 Study | 01-Sep-2026 | 07:00 | RNS |
| Major Scottish Hospital Adopts Steriwave | 30-Jul-2026 | 07:00 | RNS |
| Update on US Phase 3 Pivotal Study | 13-Jul-2026 | 07:00 | RNS |
| Result of AGM and voting results | 30-Jun-2026 | 18:15 | RNS |
| Leeds drops SSI 78% over Mupirocin with Steriwave | 30-Jun-2026 | 07:00 | RNS |
| Update on US Phase 3 Pivotal Study | 22-Jun-2026 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 9.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 15.00p |
| 52 Week Low | 8.00p |
| Volume | 0 |
| Shares Issued | 561.22m |
| Market Cap | £54.72m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 0 @ 0.000p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research